COGENTIX MEDICAL INC /DE/
Healthcare · Electromedical & Electrotherapeutic Apparatus · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | |
|---|---|---|---|---|---|---|
| Revenue | — | — | $26.5M | $24.6M | $22.4M | $3.4M |
| Operating income | −$889,474 | −$1.8M | −$5.9M | −$7.4M | −$8.5M | −$10.1M |
| Net income | −$882,750 | −$22.1M | −$7.0M | −$7.7M | −$10.6M | −$2.6M |
| Total assets | $74.7M | $73.4M | $49.0M | $10.8M | $11.4M | $12.6M |
| Total liabilities | $10.7M | $10.1M | $32.0M | $25.3M | $20.0M | $13.0M |
| Equity | $64.0M | $63.2M | $17.0M | −$14.5M | −$8.6M | −$449,000 |
| EPS (diluted) | — | — | — | — | — | — |
| Shares out. | 60.4M | 26.0M | 26.3M | 47.5M | 46.2M | 46.2M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2017- Operating margin
- —
- Net margin
- —
- Return on equity
- −1.4%
- Return on assets
- −1.2%
- Return on capital (ROCE)
- −1.4%
- Liabilities / assets
- 14.3%
- Debt / equity
- 0.17×
- Book value / share
- $1.06
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2017- Altman Z″ (distress)
- 5.63safe
- Accruals / assets
- −4.3%clean
- Piotroski F-Score
- 4/7mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 4 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Jul 1, 2008
- NT 10-Qmissed a reporting deadline ↗Feb 15, 2008
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylaws · Other material eventApr 24, 2018
- Entered a material agreement · Amended charter or bylaws · Other material eventMar 12, 2018
- Results of operationsFeb 6, 2018
- Results of operationsNov 7, 2017
- Results of operationsAug 1, 2017
- Results of operationsJul 18, 2017
- Shareholder voteJun 6, 2017
- Director / officer changeMay 25, 2017
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.